OFX Group Limited (ASX:OFX)

Singular Genomics Systems Cash Flow Statement

Financials in millions AUD. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Net Income	24.86	31.3	31.41	25.01	12.09
Depreciation & Amortization	5.83	5.57	4.79	3.01	4.95
Other Amortization	17.04	12.46	8.38	6.97	6.17
Loss (Gain) From Sale of Investments	1.69	8.38	-11.27	-1.46	-3.38
Loss (Gain) on Equity Investments	-0.34	-0.29	-0.24	-0.12	-
Stock-Based Compensation	1.93	3.61	3.38	2.48	1.34
Other Operating Activities	3.36	8.98	10.13	-1.3	5.21
Change in Income Taxes	1.85	-3.41	-1.16	6.32	-2.26
Change in Other Net Operating Assets	14.88	-2.7	8	5.55	-0.86
Operating Cash Flow	72.54	62.74	47.02	47.6	26.58
Operating Cash Flow Growth	15.61%	33.44%	-1.21%	79.05%	-12.86%
Capital Expenditures	-1.21	-3.02	-2.27	-0.96	-0.15
Cash Acquisitions	-	-	-73.62	-	-
Sale (Purchase) of Intangibles	-18.91	-19.42	-18.6	-10.51	-8.97
Investment in Securities	-24.97	5.68	-0.47	-3.01	5.16
Investing Cash Flow	-45.1	-16.76	-94.96	-15.67	-3.96
Long-Term Debt Issued	-	-	59.93	-	-
Long-Term Debt Repaid	-29.96	-31.29	-3.86	-4.14	-5.2
Net Debt Issued (Repaid)	-29.96	-31.29	56.07	-4.14	-5.2
Issuance of Common Stock	-	-	1.96	-	0.22
Repurchase of Common Stock	-13.7	-11.97	-	-	-
Common Dividends Paid	-	-	-	-	-7.79
Other Financing Activities	-	-	-	-2.04	-
Financing Cash Flow	-43.66	-43.26	58.03	-6.18	-12.77
Foreign Exchange Rate Adjustments	-0.87	-2.84	-1	-0.11	-5.16
Net Cash Flow	-17.09	-0.12	9.09	25.65	4.68
Free Cash Flow	71.32	59.72	44.75	46.64	26.43
Free Cash Flow Growth	19.43%	33.45%	-4.05%	76.42%	-10.49%
Free Cash Flow Margin	30.83%	24.60%	19.55%	29.44%	19.63%
Free Cash Flow Per Share	0.29	0.24	0.18	0.19	0.10
Levered Free Cash Flow	39.25	25.49	14.84	30.8	5.93
Unlevered Free Cash Flow	42.19	29.58	18.51	31.25	6.78
Change in Net Working Capital	-18.61	-3.21	4.61	-9.12	7.38

Source: S&P Global Market Intelligence. Standard template. Financial Sources.